Citation 61070

TSURUO,T: OH-HARA,T: LIDA,H: TSUKAGOSHI,S: SATO,Z: MATSUDA,I: IWASAKI,S: OKUDA,S: SHIMIZU,F: SASAGAWA,K: FUKAMI,M: FUKUDA,K: ARAKAWA,M:. (1986). RHIZOXIN, A MACROCYCLIC LACTONE ANTIBIOTIC, AS A NEW ANTITUMOR AGENT AGAINST HUMAN AND MURINE TUMOR CELLS AND THEIR VINCRISTINE-RESISTANT SUBLINES.. 46(1)

Citation Details

Title	RHIZOXIN, A MACROCYCLIC LACTONE ANTIBIOTIC, AS A NEW ANTITUMOR AGENT AGAINST HUMAN AND MURINE TUMOR CELLS AND THEIR VINCRISTINE-RESISTANT SUBLINES.
Authors	TSURUO,T: OH-HARA,T: LIDA,H: TSUKAGOSHI,S: SATO,Z: MATSUDA,I: IWASAKI,S: OKUDA,S: SHIMIZU,F: SASAGAWA,K: FUKAMI,M: FUKUDA,K: ARAKAWA,M:
Year	1986
Volume	46
Issue	1

Summary

Year: 1986

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	WEAK ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LEUROCRISTINE	WEAK ACTIVITY
8	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	LEUROCRISTINE	.

Rhizopus chinensis (MUCORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OF	RHIZOXIN	None
2	CELL CYCLE CYTOTOXICITY(G2 PHASE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RHIZOXIN	ACTIVE
10	TOXICITY ASSESSMENT(QUANTITATIVE)	TOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN VIVO	RHIZOXIN	.